Cardiol Therapeutics Files 6-K Report
Ticker: CRDL · Form: 6-K · Filed: Apr 10, 2026 · CIK: 0001702123
Sentiment: neutral
Topics: 6-K, foreign-issuer, disclosure
TL;DR
Cardiol Therapeutics filed a 6-K on 4/10/26. Standard foreign issuer report.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on April 10, 2026, reporting information as a foreign issuer. The filing includes documents such as the 6-K form itself and Exhibit 99.1, along with associated graphics. The company's mailing and business addresses are both located at 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
Why It Matters
This filing provides routine updates and disclosures for Cardiol Therapeutics Inc. as a foreign issuer, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign issuer and does not contain significant new financial or strategic information that would inherently increase risk.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Filer
- 0001702123 (company) — CIK Number
- 2026-04-10 (date) — Filing Date
- 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 10, 2026.
What is the CIK number for Cardiol Therapeutics Inc.?
The CIK number for Cardiol Therapeutics Inc. is 0001702123.
What are the company's mailing and business addresses?
Both the mailing and business addresses are 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
What are the main documents included in this filing?
The filing includes the FORM 6-K itself, EXHIBIT 99.1, and associated graphics.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2026 regarding Cardiol Therapeutics Inc. (CRDL).